Health Care and Pharma | Research Reports, News, Events, Research on Demand

Research Reports Titles

  • Global Fetal Heart Rate Detector Market Research Report 2016

    Notes: Production, means the output of Fetal Heart Rate Detector Revenue, means the sales value of Fetal Heart Rate Detector This report studies Fetal Heart Rate Detector in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering 3M (US) American Diagnostic Corporation (US) Cardionics, Inc. (US) GF Health Products, Inc. (US) Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China) Medline Industries Inc. (US) NISCO (INDIA) (India) Rudolf Riester GmbH & Co. KG (Germany) Suzuken Co., Ltd. (Japan) Welch Allyn Inc. (US) Welch Allyn Medical Equipment (Suzhou) Co., Ltd. (China) Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Fetal Heart Rate Detector in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on consumption, market share and growth rate of Fetal Heart Rate Detector in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 2900
    • Format: Pdf

  • Global Intravenous Immunoglobulin (IVIg) Market Research Report 2016

    Notes: Production, means the output of Intravenous Immunoglobulin (IVIg) Revenue, means the sales value of Intravenous Immunoglobulin (IVIg) This report studies Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer (US) Baxter International, Inc. (US) Bharat Serums and Vaccines Limited (India) Biotest AG (Germany) China Biologic Products, Inc (China) Guizhou Taibang Biological Products Co., Ltd (China) CSL Limited (Australia) CSL Behring LLC (US) Grifols, S.A (Spain) Hualan Biological Engineering Inc. (China) Kedrion S.p.A. (Italy) LFB Group (France) Octapharma AG (Switzerland) OMRIX Biopharmaceuticals Ltd (Israel) Shanghai RAAS Blood Products Co., Ltd. (China) Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China) Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on consumption, market share and growth rate of Intravenous Immunoglobulin (IVIg) in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 2900
    • Format: Pdf

  • Global Mechanical Stethoscopes Market Research Report 2016

    Notes: Production, means the output of Mechanical Stethoscopes Revenue, means the sales value of Mechanical Stethoscopes This report studies Mechanical Stethoscopes in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering 3M (US) American Diagnostic Corporation (US) Cardionics, Inc. (US) GF Health Products, Inc. (US) Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China) Medline Industries Inc. (US) NISCO (INDIA) (India) Rudolf Riester GmbH & Co. KG (Germany) Suzuken Co., Ltd. (Japan) Welch Allyn Inc. (US) Welch Allyn Medical Equipment (Suzhou) Co., Ltd. (China) Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Mechanical Stethoscopes in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on consumption, market share and growth rate of Mechanical Stethoscopes in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 2900
    • Format: Pdf

  • Global Apixaban Sales Market Report 2016

    Notes: Sales, means the sales volume of Apixaban Revenue, means the sales value of Apixaban This report studies sales (consumption) of Apixaban in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Apixaban in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Apixaban in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Argatroban Sales Market Report 2016

    Notes: Sales, means the sales volume of Argatroban Revenue, means the sales value of Argatroban This report studies sales (consumption) of Argatroban in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Argatroban in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Argatroban in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Arixtra Sales Market Report 2016

    Notes: Sales, means the sales volume of Arixtra Revenue, means the sales value of Arixtra This report studies sales (consumption) of Arixtra in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Arixtra in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Arixtra in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Bivalirudin Sales Market Report 2016

    Notes: Sales, means the sales volume of Bivalirudin Revenue, means the sales value of Bivalirudin This report studies sales (consumption) of Bivalirudin in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Bivalirudin in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Bivalirudin in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Dabigatran Etexilate Sales Market Report 2016

    Notes: Sales, means the sales volume of Dabigatran Etexilate Revenue, means the sales value of Dabigatran Etexilate This report studies sales (consumption) of Dabigatran Etexilate in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Dabigatran Etexilate in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Dabigatran Etexilate in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf

  • Global Dalteparin Sodium Sales Market Report 2016

    Notes: Sales, means the sales volume of Dalteparin Sodium Revenue, means the sales value of Dalteparin Sodium This report studies sales (consumption) of Dalteparin Sodium in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Pfizer, Inc. (US) Bayer Healthcare AG (Germany) GlaxoSmithKline Plc. (UK) Boehringer Ingelheim (Germany) Sanofi S.A. (France) Abbott India Limited (India) Aspen Holdings (South Africa) Bristol-Myers Squibb Company (US) Eisai Inc. (US) Mitsubishi Tanabe Pharma Corporation (Japan) Teva Pharmaceutical Industries Ltd. (Israel) Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Dalteparin Sodium in these regions, from 2011 to 2021 (forecast), like USA China Europe Japan India Southeast Asia Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Dalteparin Sodium in each application, can be divided into Application 1 Application 2 Application 3

    • Release Date: October 03, 2016
    • Price: USD 4000
    • Format: Pdf


Create Account



Log In Your Account